Literature DB >> 33461483

Non-neuronal cardiac acetylcholine system playing indispensable roles in cardiac homeostasis confers resiliency to the heart.

Shino Oikawa1, Yuko Kai1, Asuka Mano1, Hisayuki Ohata1, Atsushi Kurabayashi2, Masayuki Tsuda3, Yoshihiko Kakinuma4.   

Abstract

BACKGROUND: We previously established that the non-neuronal cardiac cholinergic system (NNCCS) is equipped with cardiomyocytes synthesizes acetylcholine (ACh), which is an indispensable endogenous system, sustaining cardiac homeostasis and regulating an inflammatory status, by transgenic mice overexpressing choline acetyltransferase (ChAT) gene in the heart. However, whole body biological significances of NNCCS remain to be fully elucidated. METHODS AND
RESULTS: To consolidate the features, we developed heart-specific ChAT knockdown (ChATKD) mice using 3 ChAT-specific siRNAs. The mice developed cardiac dysfunction. Factors causing it included the downregulation of cardiac glucose metabolism along with decreased signal transduction of Akt/HIF-1alpha/GLUT4, leading to poor glucose utilization, impairment of glycolytic metabolites entering the tricarboxylic (TCA) cycle, the upregulation of reactive oxygen species (ROS) production with an attenuated scavenging potency, and the downregulated nitric oxide (NO) production via NOS1. ChATKD mice revealed a decreased vagus nerve activity, accelerated aggression, more accentuated blood basal corticosterone levels with depression-like phenotypes, several features of which were accompanied by cardiac dysfunction.
CONCLUSION: The NNCCS plays a crucial role in cardiac homeostasis by regulating the glucose metabolism, ROS synthesis, NO levels, and the cardiac vagus nerve activity. Thus, the NNCCS is suggested a fundamentally crucial system of the heart.

Entities:  

Keywords:  Cardiac glucose metabolism; Nitric oxide; Reactive oxygen species; The non-neuronal cholinergic system; The vagus nerve

Year:  2021        PMID: 33461483     DOI: 10.1186/s12576-020-00787-6

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  37 in total

1.  Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart.

Authors:  Ashbeel Roy; William C Fields; Cibele Rocha-Resende; Rodrigo R Resende; Silvia Guatimosim; Vania F Prado; Robert Gros; Marco A M Prado
Journal:  FASEB J       Date:  2013-09-09       Impact factor: 5.191

2.  Acetylcholine as an age-dependent non-neuronal source in the heart.

Authors:  Obaida R Rana; Patrick Schauerte; Rahel Kluttig; Jörg W Schröder; Rory R Koenen; Christian Weber; Kay W Nolte; Joachim Weis; Rainer Hoffmann; Nikolaus Marx; Erol Saygili
Journal:  Auton Neurosci       Date:  2010-05-26       Impact factor: 3.145

3.  Donepezil, an acetylcholinesterase inhibitor against Alzheimer's dementia, promotes angiogenesis in an ischemic hindlimb model.

Authors:  Yoshihiko Kakinuma; Mutsuo Furihata; Tsuyoshi Akiyama; Mikihiko Arikawa; Takemi Handa; Rajesh G Katare; Takayuki Sato
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

4.  Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium.

Authors:  Yoshihiko Kakinuma; Tsuyoshi Akiyama; Takayuki Sato
Journal:  FEBS J       Date:  2009-08-06       Impact factor: 5.542

Review 5.  The non-neuronal cholinergic system in the heart: A comprehensive review.

Authors:  Eng Leng Saw; Yoshihiko Kakinuma; Martin Fronius; Rajesh Katare
Journal:  J Mol Cell Cardiol       Date:  2018-10-19       Impact factor: 5.000

Review 6.  The non-neuronal heart's acetylcholine in health and disease.

Authors:  B Lewartowski; U Mackiewicz
Journal:  J Physiol Pharmacol       Date:  2015-12       Impact factor: 3.011

7.  Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals.

Authors:  Cibele Rocha-Resende; Ashbeel Roy; Rodrigo Resende; Marina S Ladeira; Aline Lara; Enéas Ricardo de Morais Gomes; Vania F Prado; Robert Gros; Cristina Guatimosim; Marco A M Prado; Silvia Guatimosim
Journal:  J Mol Cell Cardiol       Date:  2012-05-14       Impact factor: 5.000

8.  A non-neuronal cardiac cholinergic system plays a protective role in myocardium salvage during ischemic insults.

Authors:  Yoshihiko Kakinuma; Tsuyoshi Akiyama; Kayo Okazaki; Mikihiko Arikawa; Tatsuya Noguchi; Takayuki Sato
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

9.  Heart-specific overexpression of choline acetyltransferase gene protects murine heart against ischemia through hypoxia-inducible factor-1α-related defense mechanisms.

Authors:  Yoshihiko Kakinuma; Masayuki Tsuda; Kayo Okazaki; Tsuyoshi Akiyama; Mikihiko Arikawa; Tatsuya Noguchi; Takayuki Sato
Journal:  J Am Heart Assoc       Date:  2013-01-18       Impact factor: 5.501

10.  Cholinergic signaling exerts protective effects in models of sympathetic hyperactivity-induced cardiac dysfunction.

Authors:  Mariana Gavioli; Aline Lara; Pedro W M Almeida; Augusto Martins Lima; Denis D Damasceno; Cibele Rocha-Resende; Marina Ladeira; Rodrigo R Resende; Patricia M Martinelli; Marcos Barrouin Melo; Patricia C Brum; Marco Antonio Peliky Fontes; Robson A Souza Santos; Marco A M Prado; Silvia Guatimosim
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more
  3 in total

1.  Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients With Alzheimer's Disease: A Nationwide Propensity Score Matching Study.

Authors:  Ming-Jer Hsieh; Dong-Yi Chen; Cheng-Hung Lee; Chia-Ling Wu; Ying-Jen Chen; Yu-Tung Huang; Shang-Hung Chang
Journal:  Front Cardiovasc Med       Date:  2022-03-16

2.  Muscarinic receptor regulation of chronic pain-induced atrial fibrillation.

Authors:  Chao Gong; Yu Ding; Feng Liang; Shuang Wu; Xiruo Tang; Hongzhang Ding; Wenjing Huang; Xiaotong Yu; Likun Zhou; Jun Li; Shaowen Liu
Journal:  Front Cardiovasc Med       Date:  2022-09-15

3.  Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications.

Authors:  Yoshihiko Kakinuma; Martin Fronius; Rajesh Katare; Eng Leng Saw; James T Pearson; Daryl O Schwenke; Pujika Emani Munasinghe; Hirotsugu Tsuchimochi; Shruti Rawal; Sean Coffey; Philip Davis; Richard Bunton; Isabelle Van Hout; Yuko Kai; Michael J A Williams
Journal:  Cardiovasc Diabetol       Date:  2021-02-22       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.